Safety and tolerability of RO6870868 were assessed by monitoring AEs, vital signs, laboratory tests, and electrocardiograms (ECGs) from baseline through the follow‐up visit. For AE classification purposes, the most up‐to‐date version of the Medical Dictionary for Regulatory Activities terminology for AEs and diseases and the Roche INN (International Non‐proprietary Name) Drug Terms and Procedures Dictionary for medications and treatments were used.

Note: The content above has been extracted from a research article, so it may not display correctly.

Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.

We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.